1. Home
  2. Analysis
  3. Micardis
  4. Brain-natriuretic-peptide-increased

Micardis and Brain natriuretic peptide increased - a phase IV clinical study of FDA data

Summary:

Brain natriuretic peptide increased is reported as a side effect among people who take Micardis (telmisartan), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Opsumit, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Brain natriuretic peptide increased when taking Micardis. It is created by eHealthMe based on reports of 26,556 people who have side effects when taking Micardis from the FDA, and is updated regularly.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

What is Brain natriuretic peptide increased?

Brain natriuretic peptide increased is found to be associated with 521 drugs and 552 conditions by eHealthMe. Check the latest studies of Brain natriuretic peptide increased.

On Aug, 09, 2026

26,556 people reported to have side effects when taking Micardis.
Among them, 22 people (0.08%) have Brain natriuretic peptide increased.

Could Micardis cause Brain natriuretic peptide increased?

Among these 22 people:

How long have people been on Micardis when they have Brain natriuretic peptide increased? *

  • < 1 month: 37.5 %
  • 1 - 6 months: 25.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 37.5 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Brain natriuretic peptide increased when taking Micardis? *

  • female: 61.9 %
  • male: 38.1 %

What is the age of people who have Brain natriuretic peptide increased when taking Micardis? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 21.05 %
  • 50-59: 0.0 %
  • 60+: 78.95 %

What are other drugs people take besides Micardis? *

  1. Adalat Cc: 5 people, 22.73%
  2. Opsumit: 5 people, 22.73%
  3. Zocor: 4 people, 18.18%
  4. Crestor: 4 people, 18.18%
  5. Lasix: 3 people, 13.64%
  6. Furosemide: 3 people, 13.64%
  7. Adcirca: 3 people, 13.64%
  8. Norvasc: 3 people, 13.64%
  9. Vioxx: 3 people, 13.64%
  10. Uptravi: 3 people, 13.64%

What are other side effects people have besides Brain natriuretic peptide increased? *

  1. Dyspnea (difficult or laboured breathing): 5 people, 22.73%
  2. Pulmonary Congestion (congestion in the lungs): 5 people, 22.73%
  3. Blood Creatinine Increased: 5 people, 22.73%
  4. Heart Attack: 4 people, 18.18%
  5. Oedema Peripheral (superficial swelling): 4 people, 18.18%
  6. Cardiac Failure Congestive: 4 people, 18.18%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 18.18%
  8. Septic Shock (shock due to blood infection): 3 people, 13.64%
  9. Joint Pain: 3 people, 13.64%
  10. Fever: 3 people, 13.64%

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 22.73%
  2. Cardiac Failure: 4 people, 18.18%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 13.64%
  4. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 9.09%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 9.09%
  6. Cardiac Failure Congestive: 2 people, 9.09%
  7. Pain: 2 people, 9.09%
  8. Constipation: 2 people, 9.09%
  9. Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 9.09%
  10. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Micardis and have Brain natriuretic peptide increased?

- Check whether Brain natriuretic peptide increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micardis:

Brain natriuretic peptide increased treatments and more:

How severe was Brain natriuretic peptide increased and when was it recovered:

Expand to all the drugs that have ingredients of telmisartan:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micardis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Brain natriuretic peptide increased:

Browse all the conditions that are associated with Brain natriuretic peptide increased:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan (the active ingredients of Micardis) and Micardis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.